Latest Industry Insights
Industry Insight
Developing Personalized Strategies To Maximize Cancer Therapy Success
Technology Networks recently spoke with Ofer Sharon, CEO of OncoHost, to learn more about ways to overcome patient resistance to immunotherapy and how proteomic profiling in oncology can aid diagnosis, prognosis and treatment of this incredibly complex disease.
Industry Insight
Which Vaccines Against COVID-19 Are in Human Clinical Trials?
Here, we outline which vaccine candidates against COVID-19 are currently in human clinical trials.
Industry Insight
Repurposing Drugs To Treat COVID-19 – Benefits and Challenges
Whilst scientists work tirelessly to develop an effective COVID-19 vaccine as a long-term preventive strategy, in parallel, researchers are also exploring the therapeutic potential of existing drugs as an efficient immediate approach. We recently had the pleasure of speaking with Alan Fletcher, VP/GM, Life Sciences at PerkinElmer, Inc. to learn about the benefits and challenges of repurposing a drug in this context.
Industry Insight
COVID-19 Vaccine Development: An Interview With GeoVax
Technology Networks spoke with David Dodd, President and CEO of GeoVax, to learn more about the vaccine candidates against COVID-19, what progress has been made in clinical testing and how the company is working to accelerate vaccine development timeframes.
Industry Insight
Degassing Technology That Could Improve HPLC and Laboratory Efficiency
In the world of analytical chemistry, liquid chromatography has become indispensable in the analyst’s toolbox. Decades of research and refinement have brought many advances, which begs the question, where else can improvements be made?
Industry Insight
Less Time Managing Inventory, More Time at the Bench? Yes Please
Lab efficiency is critical to speeding up development processes, yet many researchers find they spend more time managing consumables data than working at the bench. Lab informatics is one solution to this problem.
Industry Insight
Out of Academia a Sensor Star Is Born
As technology becomes smarter and smaller, scientists and engineers are looking to miniaturize and mobilize the testing required to keep our industries going. One such company, Lantha Sensors, was born out of academic research into new metal organic frameworks.
Industry Insight
Sartorius Supports COVID-19 Vaccine Development Efforts
Technology Networks spoke with Amelie Boulais, Vaccine Marketing Manager, Sartorius, to find out more about how Sartorius is supporting vaccine development at this critical time and the power of collaboration.
Industry Insight
COVID-19 Vaccine Development Update: An Interview With Novavax
Technology Networks recently had the pleasure of speaking with Novavax to discuss their current progress in COVID-19 vaccine development.
Industry Insight
Remdesivir and Sarilumab – COVID-19 Clinical Trials Begin
The Feinstein Institutes is collaborating with Gilead Sciences and Regeneron Pharmaceuticals in an effort to identify effective therapeutic treatments against COVID-19. Technology Networks recently had the pleasure of speaking with Kevin Tracey, CEO and President of the Feinstein Institutes for Medical Research to find out more.
Advertisement